1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3 Purity>98.0% (HPLC) Brexpiprazole Intermediate Factory
Ruifu Chemical Supply Brexpiprazole Intermediates
Brexpiprazole CAS 913611-97-9
7-Hydroxyquinolinone CAS 70500-72-0
4-Bromobenzo[b]thiophene CAS 5118-13-8
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride CAS 913614-18-3
7-(4-Chlorobutoxy)quinolin-2(1H)-imodzi CAS 913613-82-8
4-Chlorobenzo[b]thiophene CAS 66490-33-3
Dzina la Chemical | 1-(1-Benzothiophen-4-yl) piperazine Hydrochloride |
Mawu ofanana ndi mawu | Brexpiprazole Wapakatikati 2;1-Benzo[b]thien-4-yl-Piperazine Hydrochloride;1-Benzo[b]thien-4-ylpiperazine Monohydrochloride |
Nambala ya CAS | 913614-18-3 |
Nambala ya CAT | Chithunzi cha RF-PI1034 |
Stock Status | Mu Stock, Mphamvu Yopanga 100MT/Chaka |
Molecular Formula | Chithunzi cha C12H15ClN2S |
Kulemera kwa Maselo | 254.7789 |
Mtundu | Ruifu Chemical |
Kanthu | Zofotokozera |
Maonekedwe | Ufa Woyera mpaka Woyera |
Chizindikiritso | Nthawi yosungira yachitsanzo ikugwirizana ndi zomwe zili muyeso |
Kuyera / Kusanthula Njira | >99.0% (HPLC) |
Kutaya pa Kuyanika | <0.50% |
Madzi (KF) | <0.50% |
Zotsalira pa Ignition | <0.20% |
Zogwirizana nazo | (HPLC) |
Chidetso Chilichonse Chamunthu | <0.50% |
Zonse Zonyansa | <1.00% |
Infrared Spectrum | Zimagwirizana ndi Kapangidwe |
Proton NMR Spectrum | Zimagwirizana ndi Kapangidwe |
Test Standard | Enterprise Standard |
Kugwiritsa ntchito | Pakati pa Brexpiprazole (CAS: 913611-97-9) |
Phukusi: Botolo, Aluminiyamu zojambulazo thumba, 25kg/Cardboard Drum, kapena malinga ndi lamulo la kasitomala
Mkhalidwe Wosungira:Sungani m'mitsuko yosindikizidwa pamalo ozizira ndi owuma;Tetezani ku kuwala ndi chinyezi
1-(1-Benzothiophen-4-yl)piperazine Hydrochloride (CAS: 913614-18-3) ndi yapakatikati ya Brexpiprazole (CAS: 913611-97-9).Brexpiprazole ndi mtundu wa atypical antipsychotic.Ndi dopamine D2 receptor partial agonist.Monga buku la serotonin-dopamine zochita modulator, chitha kugwiritsidwa ntchito pochiza schizophrenia, komanso chithandizo chothandizira pakukhumudwa.Itha kuperekanso mphamvu komanso kulolerana ndi njira zochiritsira zomwe zidakhazikitsidwa formajor depressive disorder (MDD).Mankhwalawa amasonyeza mawonekedwe apadera a pharmacological, omwe amagwira ntchito ngati agonist pang'ono wa serotonin 5-HT1A ndi dopamine D2 receptors komanso ngati wotsutsana ndi 5-HT2A ndi noradrenaline α1B / 2C receptors, omwe ali ndi chiyanjano chofanana ndi subnanomolar.Mankhwalawa, omwe adapangidwa ndi Otsuka ndi Lundbeck, adavomerezedwa mu 2015 ndi FDA pochiza schizophrenia komanso ngati chithandizo chothandizira kuvutika maganizo.